Are Natural Capsules Ltd latest results good or bad?

Feb 13 2026 07:39 PM IST
share
Share Via
Natural Capsules Ltd's latest results are concerning, showing a net loss of ₹6.99 crores and negative operating profit margins due to rising costs and operational inefficiencies, despite slight revenue growth. The company faces significant financial challenges, including increased debt and a deteriorating balance sheet.
Natural Capsules Ltd's latest financial results reveal significant challenges within the company, particularly concerning profitability and operational efficiency. In the quarter ended September 2025, the company reported a net loss of ₹6.99 crores, which marks a substantial decline compared to the previous quarter and the same quarter last year. This loss reflects a negative trend in profitability, with the operating profit margin turning negative at -1.94%, the lowest in seven quarters.
Despite a modest revenue growth of 1.33% quarter-on-quarter and an 11.11% increase year-on-year, the company's operational performance has been severely impacted by rising costs, particularly in employee expenses and interest payments. Employee costs surged by 68.69% year-on-year, consuming a larger portion of net sales, which indicates operational inefficiencies. The interest expenses also rose significantly, reflecting higher debt levels and potentially increased borrowing costs. The financial metrics suggest a troubling disconnect between revenue growth and profitability, with the company unable to translate its sales growth into positive operating results. The profit before tax (PBT) also deteriorated, reaching negative ₹7.69 crores, indicating ongoing financial stress. Furthermore, the company's balance sheet has shown signs of strain, with fixed assets increasing significantly due to capital expenditures that have not yet yielded improved operational efficiency. Current liabilities have also risen, suggesting potential working capital issues. Overall, Natural Capsules Ltd's results indicate a company grappling with structural challenges and operational inefficiencies, leading to a revision in its evaluation. The absence of institutional investment and the company's significant underperformance relative to its sector further underscore the difficulties it faces in restoring financial health.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News